BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 23583027)

  • 1. The role of insulin-like-growth factor binding protein 2 (IGFBP2) and phosphatase and tensin homologue (PTEN) in the regulation of myoblast differentiation and hypertrophy.
    Sharples AP; Al-Shanti N; Hughes DC; Lewis MP; Stewart CE
    Growth Horm IGF Res; 2013 Jun; 23(3):53-61. PubMed ID: 23583027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylinositol 3-kinase (PI3K) signalling regulates insulin-like-growth factor binding protein-2 (IGFBP-2) production in human adipocytes.
    Wilhelm F; Kässner F; Schmid G; Kratzsch J; Laner A; Wabitsch M; Körner A; Kiess W; Garten A
    Growth Horm IGF Res; 2015 Jun; 25(3):115-20. PubMed ID: 25900365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C2 and C2C12 murine skeletal myoblast models of atrophic and hypertrophic potential: relevance to disease and ageing?
    Sharples AP; Al-Shanti N; Stewart CE
    J Cell Physiol; 2010 Oct; 225(1):240-50. PubMed ID: 20506232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High glucose-induced hypertrophy of mesangial cells is reversed by connexin43 overexpression via PTEN/Akt/mTOR signaling.
    Liu L; Hu X; Cai GY; Lv Y; Zhuo L; Gao JJ; Cui SY; Feng Z; Fu B; Chen XM
    Nephrol Dial Transplant; 2012 Jan; 27(1):90-100. PubMed ID: 21633095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential signalling mechanisms predisposing primary human skeletal muscle cells to altered proliferation and differentiation: roles of IGF-I and TNFalpha.
    Foulstone EJ; Huser C; Crown AL; Holly JM; Stewart CE
    Exp Cell Res; 2004 Mar; 294(1):223-35. PubMed ID: 14980516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of proliferating human skeletal muscle-derived cells in vitro: differential modulation of myoblast markers by TGF-beta2.
    Stewart JD; Masi TL; Cumming AE; Molnar GM; Wentworth BM; Sampath K; McPherson JM; Yaeger PC
    J Cell Physiol; 2003 Jul; 196(1):70-8. PubMed ID: 12767042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor 1 signaling regulates cytosolic sialidase Neu2 expression during myoblast differentiation and hypertrophy.
    Fanzani A; Colombo F; Giuliani R; Preti A; Marchesini S
    FEBS J; 2006 Aug; 273(16):3709-21. PubMed ID: 16869890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirtuin 1 regulates skeletal myoblast survival and enhances differentiation in the presence of resveratrol.
    Saini A; Al-Shanti N; Sharples AP; Stewart CE
    Exp Physiol; 2012 Mar; 97(3):400-18. PubMed ID: 22125309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of insulin-like growth factor binding protein-3 (IGFBP-3) in the differentiation of primary human adult skeletal myoblasts.
    Foulstone EJ; Savage PB; Crown AL; Holly JM; Stewart CE
    J Cell Physiol; 2003 Apr; 195(1):70-9. PubMed ID: 12599210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of myoblast differentiation following multiple population doublings in mouse C2 C12 cells: a model to investigate ageing?
    Sharples AP; Al-Shanti N; Lewis MP; Stewart CE
    J Cell Biochem; 2011 Dec; 112(12):3773-85. PubMed ID: 21826704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCAP knockdown by RNA interference inhibits myoblast differentiation in cultured skeletal muscle cells.
    Markert CD; Ning J; Staley JT; Heinzke L; Childers CK; Ferreira JA; Brown M; Stoker A; Okamura C; Childers MK
    Neuromuscul Disord; 2008 May; 18(5):413-22. PubMed ID: 18440815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERK2 is required for efficient terminal differentiation of skeletal myoblasts.
    Li J; Johnson SE
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1425-33. PubMed ID: 16729973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of hypoxia-inducible factor-1alpha by siRNA inhibits C2C12 myoblast differentiation.
    Ono Y; Sensui H; Sakamoto Y; Nagatomi R
    J Cell Biochem; 2006 Jun; 98(3):642-9. PubMed ID: 16440321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of CD147 induces malignant melanoma cell apoptosis via the regulation of IGFBP2 expression.
    Zhao S; Wu L; Kuang Y; Su J; Luo Z; Wang Y; Li J; Zhang J; Chen W; Li F; He Y; Tao J; Zhou J; Xu X; Peng C; Chen X
    Int J Oncol; 2018 Dec; 53(6):2397-2408. PubMed ID: 30272281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of IGFBP2, IGF-I and IGF-II in regulating long bone growth.
    Fisher MC; Meyer C; Garber G; Dealy CN
    Bone; 2005 Dec; 37(6):741-50. PubMed ID: 16183342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of DC vaccine potency by activating the PI3K/AKT pathway with a small interfering RNA targeting PTEN.
    Kim JH; Kang TH; Noh KH; Kim SH; Lee YH; Kim KW; Bae HC; Ahn YH; Choi EY; Kim JS; Lee KM; Kim TW
    Immunol Lett; 2010 Nov; 134(1):47-54. PubMed ID: 20727912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactoferrin promotes murine C2C12 myoblast proliferation and differentiation and myotube hypertrophy.
    Kitakaze T; Oshimo M; Kobayashi Y; Ryu M; Suzuki YA; Inui H; Harada N; Yamaji R
    Mol Med Rep; 2018 Apr; 17(4):5912-5920. PubMed ID: 29436684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin represses myotube hypertrophy and preserves viability of C2C12 cells during myogenesis in vitro.
    Gao H; Ao M; Wang H; Yu L
    Transplantation; 2014 Jul; 98(2):139-47. PubMed ID: 24926828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone enables growth and hypertrophy in fusion impaired myoblasts that display myotube atrophy: deciphering the role of androgen and IGF-I receptors.
    Hughes DC; Stewart CE; Sculthorpe N; Dugdale HF; Yousefian F; Lewis MP; Sharples AP
    Biogerontology; 2016 Jun; 17(3):619-39. PubMed ID: 26538344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akt-dependent proapoptotic effects of dietary restriction on late-stage management of a phosphatase and tensin homologue/tuberous sclerosis complex 2-deficient mouse astrocytoma.
    Marsh J; Mukherjee P; Seyfried TN
    Clin Cancer Res; 2008 Dec; 14(23):7751-62. PubMed ID: 19047102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.